WHO ICTRP trial

Examining non-invasive brain stimulation for the treatment of depression

ISRCTN26184028 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN26184028
Public title Examining non-invasive brain stimulation for the treatment of depression
Scientific title Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation in the augmentation of antidepressants (DOPRERA study). Efficacy, tolerability and neurophysiological changes
Primary sponsor Czech Health Research Agency
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Interventional
Phase Not Applicable
Countries Czech Republic
Conditions Depressive disorder Mental and Behavioural Disorders
Interventions Following an initial wash-out period (2-5 days), eligible subjects will receive a 6-week treatment. They will be randomly allocated in a 1:1:1 ratio (no stratification) to either dmPFC-rTMS +SSRI, HF-rTMS left DLPFC + SSRI and sham…
Registration date Jul 26, 2022
Target size 60
Secondary IDs Nil known;Nil known;NU22-04-00192
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations